Literature DB >> 20381509

Glucagon regulation of energy metabolism.

Kristy M Heppner1, Kirk M Habegger, Jonathan Day, Paul T Pfluger, Diego Perez-Tilve, Brian Ward, Vasily Gelfanov, Steve C Woods, Richard DiMarchi, Matthias Tschöp.   

Abstract

Glucagon has long been known as a counter-regulatory hormone to insulin of fundamental importance to glucose homeostasis. Its prominent ability to stimulate glycogenolysis and gluconeogenesis, has historically cast this peptide as one hormone where the metabolic consequences of increasing blood glucose levels, especially in obesity, are viewed largely as being deleterious. This perspective may be changing in light of emerging data and reconsideration of historic studies, which suggest that glucagon has beneficial effects on body fat mass, food intake, and energy expenditure. In this review, we discuss the mechanisms of glucagon-mediated body weight regulation as well as possible novel therapeutic approaches in the treatment of obesity and glucose intolerance that may arise from these findings. The paper represents an invited review by a symposium, award winner or keynote speaker at the Society for the Study of Ingestive Behavior [SSIB] Annual Meeting in Portland, July 2009. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20381509     DOI: 10.1016/j.physbeh.2010.03.019

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  21 in total

Review 1.  Minireview: Glucagon in stress and energy homeostasis.

Authors:  B J Jones; T Tan; S R Bloom
Journal:  Endocrinology       Date:  2012-01-31       Impact factor: 4.736

Review 2.  Gastrointestinal hormones and regulation of gastric emptying.

Authors:  Michael Camilleri
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-02       Impact factor: 3.243

Review 3.  Glucocorticoid effects on adiponectin expression.

Authors:  Siddharth Sukumaran; Debra C Dubois; William J Jusko; Richard R Almon
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

4.  Regulation of Hepatic Lipid and Glucose Metabolism by INSP3R1.

Authors:  Rachel J Perry
Journal:  Diabetes       Date:  2022-09-01       Impact factor: 9.337

5.  Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling.

Authors:  Sarah H Lockie; Kristy M Heppner; Nilika Chaudhary; Joseph R Chabenne; Donald A Morgan; Christelle Veyrat-Durebex; Gayathri Ananthakrishnan; Françoise Rohner-Jeanrenaud; Daniel J Drucker; Richard DiMarchi; Kamal Rahmouni; Brian J Oldfield; Matthias H Tschöp; Diego Perez-Tilve
Journal:  Diabetes       Date:  2012-08-28       Impact factor: 9.461

6.  Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy.

Authors:  Tingqing Guo; Nichole D Bond; William Jou; Oksana Gavrilova; Jennifer Portas; Alexandra C McPherron
Journal:  Diabetes       Date:  2012-05-17       Impact factor: 9.461

Review 7.  Obesity and appetite control.

Authors:  Keisuke Suzuki; Channa N Jayasena; Stephen R Bloom
Journal:  Exp Diabetes Res       Date:  2012-08-01

8.  Menin liver-specific hemizygous mice challenged with high fat diet show increased weight gain and markers of metabolic impairment.

Authors:  L Wuescher; K Angevine; P R Patel; E Mensah-Osman
Journal:  Nutr Diabetes       Date:  2012-05-28       Impact factor: 5.097

9.  Glucagon transiently stimulates mTORC1 by activation of an EPAC/Rap1 signaling axis.

Authors:  Siddharth Sunilkumar; Scot R Kimball; Michael D Dennis
Journal:  Cell Signal       Date:  2021-04-17       Impact factor: 4.850

10.  Fibroblast growth factor 21 mediates specific glucagon actions.

Authors:  Kirk M Habegger; Kerstin Stemmer; Christine Cheng; Timo D Müller; Kristy M Heppner; Nickki Ottaway; Jenna Holland; Jazzminn L Hembree; David Smiley; Vasily Gelfanov; Radha Krishna; Ayman M Arafat; Anish Konkar; Sara Belli; Martin Kapps; Stephen C Woods; Susanna M Hofmann; David D'Alessio; Paul T Pfluger; Diego Perez-Tilve; Randy J Seeley; Morichika Konishi; Nobuyujki Itoh; Alexei Kharitonenkov; Joachim Spranger; Richard D DiMarchi; Matthias H Tschöp
Journal:  Diabetes       Date:  2013-01-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.